Institution statistics

UCB BIOPHARMA SRL - BE 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:> 1000
Total Number of Projects:400-500
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 22
As coordinator: 0
As participant: 22
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 17.570.694 0 2
2019 0 84.254.102 0 8
2018 0 165.669.915 0 8
2017 0 14.045.356 0 3
2016 0 11.000.000 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
PFIZER LIMITED16
JANSSEN PHARMACEUTICA NV14
NOVARTIS PHARMA12
ELI LILLY AND COMPANY LIMITED9
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT9
F HOFFMANNLA ROCHE8
BAYER AKTIENGESELLSCHAFT7
ABBVIE INC6
KAROLINSKA INSTITUTE6
NOVO NORDISK6
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT6
ASTRAZENECA5
BAYER5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG5
SANOFIAVENTIS5
STICHTING KATHOLIEKE UNIVERSITEIT5
TAKEDA DEVELOPMENT CENTRE EUROPE5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD5
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE4
H LUNDBECK AS4
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
KATHOLIEKE UNIVERSITEIT LEUVEN4
KING'S COLLEGE LONDON4
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN4
MERCK SHARP & DOHME CORP4
TEVA PHARMACEUTICAL INDUSTRIES LIMITED4
UNIVERSITAIR MEDISCH CENTRUM UTRECHT4
UNIVERSITY OF NEWCASTLE UPON TYNE4
ASTRAZENECA AB3
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
EUROPEAN PATIENTS' FORUM3
GRUNENTHAL3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUT DE RECHERCHES SERVIER3
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE3
SANOFIAVENTIS DEUTSCHLAND3
SERVICIO MADRILENO DE SALUD3
STICHTING LYGATURE3
TARTU ULIKOOL3
THE SYNERGIST3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF COPENHAGEN3
UNIVERSITY OF DUNDEE3
UNIVERSITY OF GLASGOW3
UPPSALA UNIVERSITET3
ACADEMISCH ZIEKENHUIS GRONINGEN2
AMGEN LIMITED2
ARTTIC2
BIOGEN IDEC LIMITED2
BRISTOLMYERS SQUIBB COMPANY CORP2
CELGENE MANAGEMENT SARL2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS2
CONSIGLIO NAZIONALE DELLE RICERCHE2
COVANCE LABORATORIES2
DREEM2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
EUROPEAN AIDS TREATMENT GROUP EV2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION2
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES2
FORUM DES PATIENTS EUROPEENS2
FUJIFILM CELLULAR DYNAMICS INC2
FUNDACIO SANT JOAN DE DEU2
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA2
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
MEDIZINISCHE UNIVERSITAET WIEN2
NOLDUS INFORMATION TECHNOLOGY BV2
ORION OYJ2
OSPEDALE PEDIATRICO BAMBINO GESU2
PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG2
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU2
RIJKSUNIVERSITEIT GRONINGEN2
SEMMELWEIS EGYETEM2
STATENS LEGEMIDDELVERK2
STICHTING BURO ECNP2
STICHTING MLC FOUNDATION2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
SYNTHON BIOPHARMACEUTICALS BV2
TAKEDA PHARMACEUTICALS INTERNATIONAL2
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY2
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE2
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA2
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN2
THE UNIVERSITY OF EDINBURGH2
THE UNIVERSITY OF LIVERPOOL2
THE UNIVERSITY OF MANCHESTER2
TMF TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV2
UNIVERSIDAD POLITECNICA DE MADRID2
UNIVERSITAT WIEN2
UNIVERSITEIT GENT2
UNIVERSITY OF BRISTOL2
UNIVERSITY OF EASTERN FINLAND2
UNIVERSITY OF OSLO2
UNIVERSITY OF TAMPERE2
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV2
VITAL TRANSFORMATION2
Constancy:

Total number of partners:608

Partner loyalty:
Frequent Partner: (> 2 projects): 229
Rare Partner: 379

Frequent / Rare Partner Ratio: 0.6

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2020-11-01Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment Gravitate-Healthparticipant9.280.00040
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52346
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99831
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-04-01Biomarkers in Atopic Dermatitis and Psoriasis BIOMAPparticipant10.500.00032
2019-03-01Neurotoxicity De-Risking in Preclinical Drug Discovery NeuroDeRiskparticipant5.331.00018
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64816
2019-02-01Continuous Downstream Processing of Bioproducts CODOBIOparticipant3.991.00820
2019-02-01PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease PD-MitoQUANTparticipant4.497.93514
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-06-01Autism Innovative Medicine Studies – 2 – Trials AIMS-2-TRIALSparticipant54.999.99948
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2018-05-01Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production iConsensusparticipant4.700.00019
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00048
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2016-04-01Remote Assessment of Disease and Relapse in Central Nervous System Disorders - Sofia ref.: 115902 RADAR-CNSparticipant11.000.00025
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum